billy,
good analysis of where select are at ... there's no doubt the burnett institute have done some great research ... commercialising it is another matter, but i'm in select for burnett's hep c payoff.
a good announcement on hep e should not be far away; it won't take much revenue for select to be re-rated.
Add to My Watchlist
What is My Watchlist?